HRQOL in Locally Advanced Thyroid Carcinoma

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2026

Conditions

Thyroid CancerTyrosine Kinase InhibitorHealth Related Quality of Life

Interventions

DRUG

Tyrosine kinase inhibitor drugs.

TKI drugs were used at least 8 weeks. Imaging exam would be taken every four weeks.

Trial Locations (1)

RECRUITING

Road Fuma No.420, Fuzhou

All Listed Sponsors

lead

Fujian Cancer Hospital

OTHER_GOV